13.95
price up icon3.41%   0.46
 
loading

Finanzdaten der Bioventus Inc-Aktie (BVS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-27 2026-03-28 2025-12-31 2025-09-27 2025-06-28
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
15.99%
153.21
132.09 157.90 138.65 147.66
Cost Of Revenue
15.06%
47.54
41.32 49.12 44.42 45.57
Gross Profit
16.41%
105.67
90.77 108.78 94.23 102.09
Selling, General, and Administrative
5.64%
82.74
78.33 - - -
Depreciation and Amortization
5.96%
1.041
1.107 1.297 1.398 1.439
Operating Income/Loss
127.27%
19.13
8.416 19.49 11.25 18.37
Nonoperating Income/Loss
2.05%
-3.819
-3.899 -5.343 -6.582 -8.055
Income/Loss From Continuing Operations Before Tax
238.90%
15.31
4.517 14.14 4.67 10.31
Income Tax Expense/Benefit
3,760%
-20.90
0.571 -3.175 0.664 1.041
Net Income/Loss
817.51%
36.20
3.946 17.32 4.006 9.272
Attributable To Noncontrolling Interest
231.81%
2.764
0.833 2.563 0.851 1.813
Basic Average Shares
0.85%
67.87
67.30 0.1395 66.92 66.50
Diluted Average Shares
1.19%
70.84
70.01 0.1228 68.84 68.54
Basic Earnings Per Share
880.00%
0.49
0.05 0.22 0.05 0.11
Diluted Earnings Per Share
1,075%
0.47
0.04 0.21 0.05 0.11
$17.74
price up icon 5.34%
$14.21
price up icon 11.36%
$20.54
price up icon 4.48%
$10.68
price down icon 0.37%
$13.33
price down icon 0.89%
$27.68
price up icon 6.46%
Kapitalisierung:     |  Volumen (24h):